Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 24 May 2021

Molecular Identification and Genetic Characterization of Early-Stage Multiple Primary Lung Cancer by Large-Panel Next-Generation Sequencing Analysis

in Thoracic Oncology

Guotian Pei
Mingwei Li
Xianjun Min
Qiang Liu
Dasheng Li
Yingshun Yang
Shuai Wang
Xiaoyu Wang
Huina Wang
Huanqing Cheng

Frontiers in Oncology

doi 10.3389/fonc.2021.653988

9,162 views
29 citations

Original Research

Published on 24 May 2021

Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers

in Thoracic Oncology

Janna Berg
Christina Ramberg
Jon Olav Sulheim Haugstvedt
May-Bente Bengtson
Anne-Marie Gabrielsen
Odd Terje Brustugun
Ann Rita Halvorsen
Åslaug Helland

Frontiers in Oncology

doi 10.3389/fonc.2021.674731

6,915 views
19 citations

Original Research

Published on 24 May 2021

Development and Validation of a Combined Model for Preoperative Prediction of Lymph Node Metastasis in Peripheral Lung Adenocarcinoma

in Thoracic Oncology

Qi Li
Xiao-qun He
Xiao Fan
Chao-nan Zhu
Jun-wei Lv
Tian-you Luo

Frontiers in Oncology

doi 10.3389/fonc.2021.675877

4,574 views
16 citations

Original Research

Published on 21 May 2021

High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis

in Thoracic Oncology

Qianqian Wang
Liangyu Li
Tianyu Qu
Jie Li
Lingxiang Wu
Kening Li
Ziyu Wang
Mengyan Zhu
Bin Huang
Wei Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.644575

5,205 views
20 citations

Mini Review

Published on 21 May 2021

Beyond Conventional: The New Horizon of Targeted Therapy for the Treatment of Advanced Non Small Cell Lung Cancer

in Thoracic Oncology

Alfredo Tartarone
Vittoria Lapadula
Concetta Di Micco
Gemma Rossi
Carlotta Ottanelli
Andrea Marini
Roberta Giorgione
Katia Ferrari
Martina Catalano
Luca Voltolini

Frontiers in Oncology

doi 10.3389/fonc.2021.632256

7,031 views
11 citations

Original Research

Published on 20 May 2021

Methylation Regulation of TLR3 on Immune Parameters in Lung Adenocarcinoma

in Thoracic Oncology

Ang Li
Hongjiao Wu
Qinqin Tian
Yi Zhang
Zhi Zhang
Xuemei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.620200

3,324 views
6 citations

Original Research

Published on 18 May 2021

The Value of PETRA in Pulmonary Nodules of <3 cm Among Patients With Lung Cancer

in Thoracic Oncology

Hui Feng
Gaofeng Shi
Hui Liu
Yu Du
Ning Zhang
Yaning Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.649625

3,820 views
4 citations

Original Research

Published on 17 May 2021

Surgery Plus Chemotherapy Versus Surgery Alone for Limited-Stage Small-Cell Lung Cancer: A Population-Based Survival Outcome Analysis

in Thoracic Oncology

Pingting Ye
Zhuolin Guo
Yanfei Zhang
Chunyan Dong
Ming Li

Frontiers in Oncology

doi 10.3389/fonc.2021.676598

6,215 views
6 citations

Original Research

Published on 14 May 2021

Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer

in Thoracic Oncology

Xiaohong Xie
Liqiang Wang
Xinni Wang
Wan-Hung Fan
Yinyin Qin
Xinqing Lin
Zhanhong Xie
Ming Liu
Ming Ouyang
Shiyue Li

Frontiers in Oncology

doi 10.3389/fonc.2021.672687

7,316 views
34 citations

Editorial

Published on 14 May 2021

Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy

in Thoracic Oncology

Umberto Malapelle
Etienne Giroux Leprieur
Paul Takam Kamga
Marius Tresor Chiasseu
Christian Rolfo

Frontiers in Oncology

doi 10.3389/fonc.2021.694578

3,854 views
7 citations

Original Research

Published on 14 May 2021

Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

in Thoracic Oncology

Yuhui Ma
Quan Li
Yaxi Du
Jingjing Cai
Wanlin Chen
Guangqiang Zhao
Xing Liu
Hongsheng Li
Luyao Ma
Yunchao Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.640761

4,823 views
11 citations

Original Research

Published on 13 May 2021

Phenotypic Plasticity Conferred by the Metastatic Microenvironment of the Brain Strengthens the Intracranial Tumorigenicity of Lung Tumor Cells

in Thoracic Oncology

Xu-Ge Wei
Ke-Wei Bi
Bo Li

Frontiers in Oncology

doi 10.3389/fonc.2021.637911

3,564 views
5 citations

Original Research

Published on 13 May 2021

Age-Associated Changes in Adverse Events Arising From Anti-PD-(L)1 Therapy

in Thoracic Oncology

Xinyi Huang
Tiantian Tian
Yan Zhang
Shengjian Zhou
Pingping Hu
Jiandong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.619385

5,539 views
30 citations

Systematic Review

Published on 11 May 2021

Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review

in Thoracic Oncology

Tao Ouyang
Yanyan Cao
Xuefeng Kan
Lei Chen
Yanqiao Ren
Tao Sun
Liangliang Yan
Bin Xiong
Bin Liang
Chuansheng Zheng

Frontiers in Oncology

doi 10.3389/fonc.2021.621639

7,416 views
21 citations

Original Research

Published on 07 May 2021

Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study

in Thoracic Oncology

Zhengbo Song
Dongqing Lv
Shiqing Chen
Jianhui Huang
Liping Wang
Shuguang Xu
Huafei Chen
Guoqiang Wang
Quan Lin

Frontiers in Oncology

doi 10.3389/fonc.2021.657283

6,293 views
16 citations

Original Research

Published on 07 May 2021

The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm

in Thoracic Oncology

Hua Zhang
Wuhao Huang
Chang Liu
Giuseppe Giaccone
Xiaoliang Zhao
Xiaoyan Sun
Jingjing Li
Runfen Cheng
Qiujuan Huang
Huilan Mo

Frontiers in Oncology

doi 10.3389/fonc.2021.657506

5,737 views
11 citations

Original Research

Published on 07 May 2021

Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching’s Study

in Thoracic Oncology

Bo Zhang
Renwang Liu
Dian Ren
Xiongfei Li
Yanye Wang
Huandong Huo
Shuai Zhu
Jun Chen
Zuoqing Song
Song Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.610638

5,689 views
29 citations

Original Research

Published on 06 May 2021

Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer

in Thoracic Oncology

Maria Gabriela O. Fernandes
Catarina Sousa
Maria Jacob
Leonor Almeida
Vanessa Santos
David Araújo
Hélder Novais Bastos
Adriana Magalhães
Luís Cirnes
Conceição Souto Moura

Frontiers in Oncology

doi 10.3389/fonc.2021.602924

5,820 views
8 citations

Original Research

Published on 04 May 2021

The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer

in Thoracic Oncology

Giuseppe Bronte
Maurizio Puccetti
Elisabetta Petracci
Lorenza Landi
Paola Cravero
Simona Scodes
Paola Ulivi
Sara Ravaioli
Maria Maddalena Tumedei
Marco Angelo Burgio

Frontiers in Oncology

doi 10.3389/fonc.2021.669839

3,435 views
7 citations

Review

Published on 04 May 2021

Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer

in Thoracic Oncology

Likui Fang
Wuchen Zhao
Bo Ye
Da Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.670313

5,449 views
23 citations

Review

Published on 03 May 2021

KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup

in Thoracic Oncology

Mingying Xie
Xiaoling Xu
Yun Fan

Frontiers in Oncology

doi 10.3389/fonc.2021.672612

27,169 views
73 citations

Original Research

Published on 30 Apr 2021

Integrating Histologic and Genomic Characteristics to Predict Tumor Mutation Burden of Early-Stage Non-Small-Cell Lung Cancer

in Thoracic Oncology

Yuan Qiu
Liping Liu
Haihong Yang
Hanzhang Chen
Qiuhua Deng
Dakai Xiao
Yongping Lin
Changbin Zhu
Weiwei Li
Di Shao

Frontiers in Oncology

doi 10.3389/fonc.2020.608989

7,556 views
17 citations

Original Research

Published on 29 Apr 2021

Radiomics-Based Features for Prediction of Histological Subtypes in Central Lung Cancer

in Thoracic Oncology

Huanhuan Li
Long Gao
He Ma
Dooman Arefan
Jiachuan He
Jiaqi Wang
Hu Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.658887

6,597 views
42 citations

Original Research

Published on 29 Apr 2021

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study

in Thoracic Oncology

Krittiya Korphaisarn
Pongwut Danchaivijitr
Thanyanan Reungwetwattana
Busayamas Chewaskulyong
Luangyot Thongthieang
Jarin Chindaprasirt
Kunlatida Maneenil
Chirawadee Sathitruangsak
Chanida Vinayanuwattikun

Frontiers in Oncology

doi 10.3389/fonc.2021.572740

4,542 views
6 citations

1,972 articles

articles

Molecular Identification and Genetic Characterization of Early-Stage Multiple Primary Lung Cancer by Large-Panel Next-Generation Sequencing Analysis

Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers

Development and Validation of a Combined Model for Preoperative Prediction of Lymph Node Metastasis in Peripheral Lung Adenocarcinoma

High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis

Beyond Conventional: The New Horizon of Targeted Therapy for the Treatment of Advanced Non Small Cell Lung Cancer

Methylation Regulation of TLR3 on Immune Parameters in Lung Adenocarcinoma

The Value of PETRA in Pulmonary Nodules of <3 cm Among Patients With Lung Cancer

Surgery Plus Chemotherapy Versus Surgery Alone for Limited-Stage Small-Cell Lung Cancer: A Population-Based Survival Outcome Analysis

Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer

Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy

Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Phenotypic Plasticity Conferred by the Metastatic Microenvironment of the Brain Strengthens the Intracranial Tumorigenicity of Lung Tumor Cells

Age-Associated Changes in Adverse Events Arising From Anti-PD-(L)1 Therapy

Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review

Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study

The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm

Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching’s Study

Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer

The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer

Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer

KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup

Integrating Histologic and Genomic Characteristics to Predict Tumor Mutation Burden of Early-Stage Non-Small-Cell Lung Cancer

Radiomics-Based Features for Prediction of Histological Subtypes in Central Lung Cancer

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study